Publications by authors named "Stephen D Silberstein"

Claim this Profile
I
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.
Hsiangkuo Yuan, Serena L Orr, Mohammad A M Al-Karagholi, Messoud Ashina, Fred Cohen, Stephen D Silberstein

Cephalalgia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations.
Yasmine Hoydonckx, Alexander Feoktistov, Farnaz Amoozegar, Christopher C Anderson, Meredith Barad, Stephen D Silberstein

Reg Anesth Pain Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data.
Marina Vives-Mestres, Amparo Casanova, Stephen D Silberstein, Andrew D Hershey, Serena L Orr

Headache· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management.
Patricia Pozo-Rosich, Alicia Alpuente, Stephen D Silberstein, Rami Burstein

Nat Rev Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.
Stephen D Silberstein, Hans-Christoph Diener, David W Dodick, Katherine Sommer, Richard B Lipton

Headache· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How early can we treat migraine attacks? A perspective based on prodrome.
Hsiangkuo Yuan, Stephen D Silberstein

Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based preventive treatment of migraine.
Callum W Duncan, Stephen D Silberstein

Handb Clin Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Free Noninvasive Thermal Nerve Block: Validation of Sham Devices.
Michael A Fishman, Ahish Chitneni, Alaa Abd-Elsayed, Samuel Grodofsky, Ashley M Scherer, Stephen D Silberstein

Brain Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact.
Catherine C Turkel, Sheena Aurora, Hans-Christoph Diener, David W Dodick, Richard B Lipton, Stephen D Silberstein

Medicine (Baltimore)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, David Kudrow, Messoud Ashina

Headache· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging pharmacotherapy for menstrual migraine: a narrative review.
Claire E J Ceriani, Stephen D Silberstein

Expert Opin Pharmacother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System.
Stephen D Silberstein, Shoshana Reshef, Joshua M Cohen, Sanjay Gandhi, Michael Seminerio

Adv Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 edition.
Todd J Schwedt, Cristina Tassorelli, Stephen D Silberstein, Christina L Szperka, Tobias Kurth

Cephalalgia· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.
Christian Lampl, Alan M Rapoport, Joshua M Cohen, Steve Barash, Verena Ramirez Campos, Stephen D Silberstein

Eur J Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
Hans Christoph Diener, Peter McAllister, Tim P Jürgens, Yoel Kessler, Xiaoping Ning, Stephen D Silberstein

Cephalalgia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lidocaine infusions for refractory chronic migraine: a retrospective analysis.
Eric S Schwenk, Aaron Walter, Marc C Torjman, Sarah Mukhtar, Harsh T Patel, Stephen D Silberstein

Reg Anesth Pain Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
Fred Cohen, Hsiangkuo Yuan, Stephen D Silberstein

BioDrugs· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine.
Fred Cohen, Hsiangkuo Yuan, E M G DePoy, Stephen D Silberstein

Neurotherapeutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
Todd J Schwedt, Richard B Lipton, Jessica Ailani, Stephen D Silberstein, Cristina Tassorelli

Cephalalgia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis.
Eric S Schwenk, Marc C Torjman, Ruin Moaddel, Jacqueline Lovett, Daniel Katz, Stephen D Silberstein

J Clin Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
Cristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, David W Dodick, Peter J Goadsby

Cephalalgia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study.
Hsiangkuo Yuan, John G Curran, Scott W Keith, Mary M Hopkins, Stephen D Silberstein

Headache· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
Susan Hutchinson, Stephen D Silberstein, Andrew M Blumenfeld, Richard B Lipton, Kaifeng Lu

Cephalalgia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
Ryotaro Ishii, Todd J Schwedt, Gina Dumkrieger, Nim Lalvani, Audrey Craven, Stephen D Silberstein

Headache· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new hypothesis linking oxytocin to menstrual migraine.
Vimala N Bharadwaj, Frank Porreca, Robert P Cowan, Shashidhar Kori, Stephen D Silberstein

Headache· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis